HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bernard Klein Selected Research

Bernard Klein Research Topics

Disease

53Multiple Myeloma
03/2019 - 04/2002
27Neoplasms (Cancer)
06/2017 - 08/2002
5Chromosome Aberrations (Chromosome Abnormalities)
11/2015 - 04/2009
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2016 - 03/2009
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2011 - 02/2007
2Testicular Neoplasms (Testicular Cancer)
04/2011 - 07/2009
2Starvation
10/2007 - 05/2003
1COVID-19
01/2021
1Monoclonal Gammopathy of Undetermined Significance
01/2019
1Lymphoma (Lymphomas)
01/2016
1Hematologic Neoplasms (Hematological Malignancy)
01/2016
1Carcinogenesis
01/2016
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016
1Inflammation (Inflammations)
03/2015
1Anemia
03/2015
1Castleman Disease (Castleman's Disease)
03/2015
1Rheumatoid Arthritis
03/2015
1Bone Diseases (Bone Disease)
02/2015
1Disease Progression
01/2014
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2013
1Ewing Sarcoma (Sarcoma, Ewing)
12/2012
1Prostatic Neoplasms (Prostate Cancer)
12/2012
1Residual Neoplasm
11/2012
1Paraproteinemias (Monoclonal Gammopathy)
07/2011
1Myocardial Infarction
07/2011
1Neoplasm Metastasis (Metastasis)
04/2010
1Trisomy (Trisomies)
04/2010
1Lymphopenia (Lymphocytopenia)
01/2010

Drug/Important Bio-Agent (IBA)

8Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2015 - 08/2003
6AntigensIBA
03/2013 - 04/2006
5DNA (Deoxyribonucleic Acid)IBA
11/2015 - 10/2002
5Interleukin-6 (Interleukin 6)IBA
03/2015 - 05/2003
4Melphalan (Alkeran)FDA LinkGeneric
03/2019 - 01/2010
4Pharmaceutical PreparationsIBA
03/2015 - 12/2007
3Lenalidomide (CC 5013)FDA Link
05/2016 - 07/2011
3Biological ProductsIBA
11/2015 - 01/2008
3CytokinesIBA
03/2013 - 01/2010
3Proteins (Proteins, Gene)FDA Link
12/2012 - 01/2011
3Peptides (Polypeptides)IBA
01/2010 - 04/2006
3Syndecan-1 (Syndecan 1)IBA
08/2009 - 06/2007
3T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
07/2009 - 04/2006
3Proteoglycans (Proteoglycan)IBA
05/2009 - 06/2007
3Heparin (Liquaemin)FDA LinkGeneric
05/2009 - 05/2005
2tocilizumab (atlizumab)FDA Link
01/2021 - 03/2015
2MicroRNAs (MicroRNA)IBA
06/2017 - 11/2015
2Thalidomide (Thalomid)FDA Link
05/2016 - 03/2013
2InterferonsIBA
03/2013 - 03/2011
2Rituximab (Mabthera)FDA Link
03/2011 - 06/2008
2Monoclonal AntibodiesIBA
03/2011 - 10/2003
2Interleukin-2 (IL2)IBA
03/2011 - 10/2007
2thymosin beta(4)IBA
04/2010 - 01/2010
2bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
08/2009 - 03/2009
2Messenger RNA (mRNA)IBA
07/2009 - 12/2008
2Neoplasm Antigens (Tumor Antigens)IBA
07/2009 - 08/2002
2HLA Antigens (Human Leukocyte Antigens)IBA
07/2009 - 04/2006
2Heparitin Sulfate (Heparan Sulfate)IBA
03/2009 - 06/2007
2ErbB Receptors (EGF Receptor)IBA
03/2004 - 04/2002
1AntioxidantsIBA
03/2019
1Bromodeoxyuridine (BrdU)IBA
01/2019
1pomalidomideIBA
05/2016
1chetominIBA
03/2016
1RecQ HelicasesIBA
01/2016
1Acute-Phase Proteins (Acute-Phase Protein)IBA
03/2015
1Interleukin-6 InhibitorsIBA
03/2015
1siltuximabIBA
03/2015
1MethyltransferasesIBA
02/2015
1Histone Deacetylase InhibitorsIBA
02/2015
1Insulin-Like Growth Factor Binding ProteinsIBA
02/2015
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
02/2015
1SurvivinIBA
11/2014
1sepantroniumIBA
11/2014
1A-Form DNA (A-DNA)IBA
05/2014
1Alkylating AgentsIBA
09/2013
1Immunoglobulins (Immunoglobulin)IBA
09/2013
1NucleotidesIBA
06/2013
1Carcinoembryonic AntigenIBA
05/2013
1Cell Adhesion MoleculesIBA
05/2013
1EnzymesIBA
01/2013
1Polysaccharides (Glycans)IBA
01/2013
1Proteasome InhibitorsIBA
11/2012
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2012
1Annexin A2 (Annexin II)IBA
08/2012
1Bortezomib (Velcade)FDA Link
03/2012
1Growth Differentiation Factor 15IBA
03/2012
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
05/2011
1SulfatasesIBA
05/2011
1ofatumumabFDA Link
03/2011
1PerforinIBA
03/2011
1Granzymes (Granzyme)IBA
03/2011
1Complement System Proteins (Complement)IBA
03/2011
1bromohydrin pyrophosphateIBA
03/2011
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
04/2010
1ThymosinIBA
01/2010
1Indicators and Reagents (Reagents)IBA
08/2009

Therapy/Procedure

11Therapeutics
03/2015 - 10/2003
9Immunotherapy
05/2013 - 04/2006
4Drug Therapy (Chemotherapy)
11/2015 - 01/2010
2Stem Cell Transplantation
03/2013 - 01/2010
1Immunomodulation
02/2015
1Transplantation
11/2012